Immunomodulators in the Treatment of Cutaneous Lymphoma
September 1999
in “
Journal of the European Academy of Dermatology and Venereology
”
cutaneous lymphoma immunomodulatory therapies Interferon-alpha IFN-α CTCL high-dose IL-2 mycophenolate mofetil cyclosporin A monoclonal antibodies autologous BMT fusion toxins thymopentin retinoids ECP extracorporeal photopheresis vaccination therapy DAB 389 IL-2 erythrodermic CTCL cutaneous lymphoma Interferon-alpha IFN-α CTCL IL-2 mycophenolate mofetil cyclosporin A monoclonal antibodies BMT fusion toxins thymopentin retinoids ECP extracorporeal photopheresis vaccination therapy DAB 389 IL-2 erythrodermic CTCL
Studysummary This review examines various immunomodulatory therapies for cutaneous lymphoma and notes that they are most effective in the disease's early stages.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer